Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Más filtros











Base de datos
Intervalo de año de publicación
1.
Med Mal Infect ; 40(2): 94-9, 2010 Feb.
Artículo en Francés | MEDLINE | ID: mdl-19793633

RESUMEN

OBJECTIVES: This monocentric, observational and retrospective survey was performed to check the appropriateness between aminoglycoside prescriptions and inhibitor quotient to be reached, in Intensive Care Unit (ICU) patients. We identified variability factors for aminoglycoside plasmatic concentrations at peak such as standardized index of gravity (IGS2 scale), age, sex, weight, and severity of sepsis. PATIENTS AND METHOD: Eighty-seven ICU patients received an antibiotic combination mandatorily including an aminoglycoside (amikacin or gentamicin) as curative treatment for a severe infection. Prescribed dosages were 15mg/kg for amikacin and 5mg/kg for gentamicin. The maximal concentration (Cmax) and minimal inhibiting concentration (MIC) of involved bacteria were recorded. The aminoglycoside ratio Cmax/MIC, called inhibitor quotient, was determined. The inhibitor quotient was considered efficient when superior to 10. The Cmax for aminoglycoside first peak was also compared with the theoretical Cmax to be reached. RESULTS: In the aminoglycoside Cmax, 50.3% were efficient (59.6% for amikacin Cmax and 38.9% for gentamicin Cmax). In 46% of the cases, the inhibitor quotient was efficient; 12.6% of Cmax reached the theoretical Cmax. Factors identified as negatively interacting with biological efficiency were: Gram-positive bacteria or anaerobic bacteria infections and planned surgery. CONCLUSION: In the inhibitor quotients, 49.7% were at inefficient rates, even when the recommended aminoglycoside dosage for was given. Therefore, dose and administration should be updated.


Asunto(s)
Amicacina/sangre , Antibacterianos/sangre , Monitoreo de Drogas , Gentamicinas/sangre , Unidades de Cuidados Intensivos , Adulto , Anciano , Anciano de 80 o más Años , Amicacina/uso terapéutico , Antibacterianos/uso terapéutico , Femenino , Gentamicinas/uso terapéutico , Humanos , Masculino , Persona de Mediana Edad , Estudios Retrospectivos , Adulto Joven
2.
Med Mal Infect ; 39(9): 735-8, 2009 Sep.
Artículo en Francés | MEDLINE | ID: mdl-19269759

RESUMEN

Serious infectious complications may appear after a surgical procedure despite antimicrobial prophylaxis. We report a case of Escherichia Coli meningitis after a prostate puncture biopsy. Many factors may have contributed to this rare complication such as fluoroquinolone resistance, and/or the bacterium's ability to cross the brain blood barrier. The patient was not found susceptible to severe infections.


Asunto(s)
Biopsia con Aguja/efectos adversos , Meningitis por Escherichia coli/tratamiento farmacológico , Meningitis por Escherichia coli/etiología , Próstata/patología , Antibacterianos/uso terapéutico , Biopsia con Aguja/métodos , Diagnóstico Diferencial , Escherichia coli/efectos de los fármacos , Humanos , Masculino , Meningitis por Escherichia coli/patología , Persona de Mediana Edad , Recto
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA